Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.
about
Proteomics and peptidomics: moving toward precision medicine in urological malignanciesFrontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinomaDevelopment and characterization of a novel mAb against bilitranslocase - a new biomarker of renal carcinoma.MALDI imaging mass spectrometry and analysis of endogenous peptides.Tetravalent antibody-scTRAIL fusion proteins with improved properties.Quantitative proteomics analysis of early recurrence/metastasis of huge hepatocellular carcinoma following radical resectionGalectin-1 and Galectin-3 mRNA expression in renal cell carcinoma.Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer.Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulationQuantitative variability of 342 plasma proteins in a human twin population.Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublinesmiRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma.Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis.Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling.Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.The urinary proteome and peptidome of renal cell carcinoma patients: a comparison of different techniques.Clinical and molecular prognostic and predictive biomarkers in clear cell renal cell cancer.Quantitative toxicoproteomic analysis of zebrafish embryos exposed to a retinoid X receptor antagonist UVI3003.Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.The proteomic landscape of renal tumors.Ambient ionization mass spectrometric analysis of human surgical specimens to distinguish renal cell carcinoma from healthy renal tissue.Comparative proteomics analysis of primary cutaneous amyloidosisIdentification of CD14 as a potential biomarker of hepatocellular carcinoma using iTRAQ quantitative proteomics.Downregulation of PDZ Domain Containing 1 (PDZK1) is a Poor Prognostic Marker for Clear Cell Renal Cell Carcinoma.Prognosis markers for metastatic renal cell carcinoma: quantitative proteomics approach.SERPINH1 overexpression in clear cell renal cell carcinoma: association with poor clinical outcome and its potential as a novel prognostic marker.A versatile reversed phase-strong cation exchange-reversed phase (RP-SCX-RP) multidimensional liquid chromatography platform for qualitative and quantitative shotgun proteomics.Elucidating mechanisms of sunitinib resistance in renal cancer: an integrated pathological-molecular analysis.Statistical detection of quantitative protein biomarkers provides insights into signaling networks deregulated in acute myeloid leukemia.High glucose-induced Galectin-1 in human podocytes implicates the involvement of Galectin-1 in diabetic nephropathy.Non-Invasive Assessment of Lactate Production and Compartmentalization in Renal Cell Carcinomas Using Hyperpolarized C Pyruvate MRI
P2860
Q26749401-BA0DB577-F9A4-4ABA-8BF1-3A2B90AE6332Q26863402-02CC7D97-879F-4E5C-B871-0850147F14C6Q30432428-E3E9C607-681D-4336-91FF-E6FC513DDFABQ31134599-4312CC5A-8724-44F1-852F-21BF141E203AQ33619046-DF209D26-5E16-4695-A08F-62CDC6A9D657Q33620725-26F29035-D2B3-407F-8A36-5CC2E3875037Q33631354-0E992FCA-34C0-4E99-8340-9135747B0E5CQ33814898-A2DD9777-C49F-4B23-A981-07DC2C328696Q35128150-53D682BD-6412-43E0-8755-159147A6B8CAQ35174121-1A604FE3-7BCB-4447-8AD4-B3F79154CA4CQ35649272-35DF58CD-FECB-4D77-ACCE-A0CAD994C090Q35828624-F058059D-CE55-4FE7-B88A-6A7BFCE163D7Q36003500-B9EFBD06-8E9B-4A58-B09B-B2BA9BB49BFDQ36006304-F88F0AE4-A175-4025-90D6-6FC19B063C74Q36738790-C7D5A60A-26B0-4C51-BCF0-BF65FAE89807Q37632111-EC084D64-E49C-40FB-A8A9-F8C36A03405EQ37650629-2684516C-AA1A-46C0-AE58-DB486F62D85AQ37660323-185E2632-A21E-486A-A034-B95F36BE1FEEQ38217103-9CD7EDE6-E541-44DA-8B0A-C0FD98C65C92Q38294622-012E11CD-3447-4468-A04A-C07198A2533BQ38467998-B1A8E8F4-C15C-4BA1-B596-5D6F14BD0E3EQ38484441-198CC4E3-6D6E-436A-AF40-42EB8559F952Q38803559-59040CAD-D6B5-4EBF-8AA6-536E12296875Q38864602-6120E536-F60C-4BA8-B244-AABCF4051DBFQ41623583-B6E11914-17F3-454F-9A58-3FF8664DA273Q41924403-F68E0169-BB09-4B75-9647-347EAB667CA8Q42197616-83D5E7F9-4F5A-4D9A-9976-29158E4D7E5BQ43872662-45503A9C-DDA3-471E-B0F5-9B44AC66EECFQ48119782-3B412FD2-2ED9-4129-999A-415AE2DA8F4BQ48393196-A43DE192-DD83-4A0E-BC3A-2F863873B31CQ49687781-740F561C-CC71-4C3A-8D17-CEF96B9B7B8CQ51039769-221A54E8-CE3E-4A78-917C-0AEBA758291FQ54192980-E95845E8-AB1C-496E-895A-A0FCEF328436Q57160517-CCA27844-F744-47CF-9D95-5B5916026347
P2860
Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Quantitative proteomic analysi ...... ntial prognostic significance.
@en
Quantitative proteomic analysi ...... ntial prognostic significance.
@nl
type
label
Quantitative proteomic analysi ...... ntial prognostic significance.
@en
Quantitative proteomic analysi ...... ntial prognostic significance.
@nl
prefLabel
Quantitative proteomic analysi ...... ntial prognostic significance.
@en
Quantitative proteomic analysi ...... ntial prognostic significance.
@nl
P2093
P2860
P356
P1476
Quantitative proteomic analysi ...... ntial prognostic significance.
@en
P2093
Ajay Matta
Alexander D Romaschin
Bishoy Khalil
George M Yousef
K W Michael Siu
Kenneth Pace
Leroi V DeSouza
Nicole M A White
Olena Masui
Olga Krakovska
P2860
P304
P356
10.1074/MCP.M112.020701
P577
2012-10-17T00:00:00Z